Uploaded July 2026 | Updated September 2026, 2 weeks ago
Four children with terminal brain cancer were saved by new cell therapy.
“These children are getting to grow up – it’s truly awesome,” says Gene Hwang at Children’s National Hospital in Washington DC.
The experimental treatment, called tumour-associated antigen (TAA) T-cell therapy, was given to 33 children and young adults with either newly diagnosed diffuse intrinsic pontine glioma (DIPG), a highly aggressive form of brain cancer, or other brain tumours that hadn’t responded to standard treatments. The trial focused on these tumour types because “they’re universally fatal, there’s nothing else for them”, says team member Catherine Bollard, also at Children’s National Hospital.
Tap the link to read more :newscientist.com/article/2533638-four-children-with-terminal-brain-cancer-saved-by-new-cell-therapy
#sciencenews #cancer #health
Four children with terminal brain cancer were saved by new cell therapy.
“These children are getting to grow up – it’s truly awesome,” says Gene Hwang at Children’s National Hospital in Washington DC.
The experimental treatment, called tumour-associated antigen (TAA) T-cell therapy, was given to 33 children and young adults with either newly diagnosed diffuse intrinsic pontine glioma (DIPG), a highly aggressive form of brain cancer, or other brain tumours that hadn’t responded to standard treatments. The trial focused on these tumour types because “they’re universally fatal, there’s nothing else for them”, says team member Catherine Bollard, also at Children’s National Hospital.
Tap the link to read more :newscientist.com/article/2533638-four-children-with-terminal-brain-cancer-saved-by-new-cell-therapy
#sciencenews #cancer #health
